Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy

1. Botton, T.
2. Yeh, I.
3. Nelson, T.
4. Vemula, S.S.
5. Sparatta, A.
6. Garrido, M.C.
7. Allegra, M.
8. Rocchi, S.
9. Bahadoran, P.
10. Mccalmont, T.H.
11. Leboit, P.E.
12. Burton, E.A.
13. Bollag, G.
14. Ballotti, R.
15. Bastian, B.C.